Posted by iforgotmypassword on April 11, 2007, at 13:25:54
there doesn't seem to be any reason to believe that it would not be successful as an antipsychotic here, being associated with a lot less to no weight gain compared to other antipsychotics, having no h1 affinity.
it would also be the first official treatment for dysthymia in north america, while that would mean absolutely nothing to most doctors, who likely just don't care about diagnoses like dysthymia, it would benefit many patients and demand would likely shoot up simply on that level.
are there any actual valid sensible reasons it is not available here?
poster:iforgotmypassword
thread:749057
URL: http://www.dr-bob.org/babble/20070407/msgs/749057.html